Daily inhalation of hydrogen gas has a blood pressure-lowering effect in a rat model of hypertension
Sugai Kazuhisa, Tamura Tomoyoshi, Sano Motoaki, Uemura Shizuka, Fujisawa Masahiko, Katsumata Yoshinori, Endo Jin, Yoshizawa Joe, Homma Koichiro, Suzuki Masaru, Kobayashi Eiji, Sasaki Junichi, Hakamata Yoji · Scientific Reports · 2020
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
The publication “Daily inhalation of hydrogen gas has a blood pressure-lowering effect in a rat model of hypertension” is organized in H2HUBB under the research focus molecular hydrogen blood pressure study 2020. The publication is cited as Sugai Kazuhisa, Tamura Tomoyoshi, Sano Motoaki, Uemura Shizuka, Fujisawa Masahiko, Katsumata Yoshinori, Endo Jin, Yoshizawa Joe, Homma Koichiro, Suzuki Masaru, Kobayashi Eiji, Sasaki Junichi, Hakamata Yoji, Scientific Reports, 2020. This animal study examined Daily inhalation of hydrogen gas has a blood pressure-lowering effect in a rat model of hypertension. The abstract describes Rat model. The abstract reports: A recent clinical study demonstrated that haemodialysis with a dialysate containing hydrogen (H) improves blood pressure control in end-stage kidney disease. This is an automated editorial draft based on the abstract and requires source review before publication.
Molecular hydrogen blood pressure study 2020 overview
The main outcome was not fully reported in the available structured record and should be checked against the original source. Animal research can identify biological effects and support future investigation, but it cannot by itself establish safety or effectiveness in humans.
Study design and hydrogen intervention
Publication type: Animal study. Evidence type: Preclinical animal evidence. Research model or population: Rat model. Blinding: Unknown. Control status: Unknown.
Delivery method: Other or not reported.
Reported findings and scientific interpretation
For this molecular hydrogen blood pressure study 2020, the study record reports the following: The abstract reports: A recent clinical study demonstrated that haemodialysis with a dialysate containing hydrogen (H) improves blood pressure control in end-stage kidney disease.
These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.
How this research record was prepared
H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.
Limitations, safety, and original source
Limitations: Preclinical animal findings may not translate directly to human outcomes.
Safety: The abstract did not provide detailed safety or adverse-event information.
This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.